Coya Therapeutics, Inc. Effective Tax Rate
Coya Therapeutics, Inc. (COYA) reported Effective Tax Rate of -0.03% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-03-16
- Coya Therapeutics, Inc. effective income tax rate reconciliation, percent for fiscal 2025 was -0.03%, a 100.65% decline from fiscal 2024.
- Coya Therapeutics, Inc. effective income tax rate reconciliation, percent for fiscal 2024 was 4.64%.
- Coya Therapeutics, Inc. effective income tax rate reconciliation, percent for fiscal 2023 was -10.10%.
- Coya Therapeutics, Inc. effective income tax rate reconciliation, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -0.03% 10-K · filed 2026-03-16 | |
| 2024-12-31 | 4.64% 10-K · filed 2026-03-16 | 4.70% 10-K · filed 2025-03-18 |
| 2023-12-31 | -10.10% 10-K · filed 2025-03-18 | 10.10% 10-K · filed 2024-03-19 |
| 2022-12-31 | 0.00% 10-K · filed 2024-03-19 | |
| 2021-12-31 | 0.00% 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |